Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 348, Issue 5, pp 536–540 | Cite as

Both β1- and β2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium

  • Alberto J. Kaumann
  • Louise Sanders
Short Communications

Summary

The involvement of β1- and β2-adrenoceptors in catecholamine-evoked arrhythmias was investigated in isolated human right atrial appendages obtained from 22 patients chronically treated with β blockers (usually β1-selective) and 9 patients not treated with β blockers. A simple experimental model that assesses the incidence of arrhythmic contractions as a function of heart rate (pacing) is introduced. β1-adrenoceptors were activated by (−)-noradrenaline during β2-adrenoceptor blockade with 50 nmol/l ICI 118551. β2-adrenoceptors were activated by (−)-adrenaline during β1-adrenoceptor blockade with 300 nmol/l CGP 20712A. Both (−)noradrenaline and (−)-adrenaline caused arrhythmic contractions whose incidence was greater at low than at high pacing rates. CGP 20712A (300 nmol/l) blocked the (−)-noradrenaline-evoked contractions in 1/1 atrial strip from 1/1 patient not treated with a β blocker and 17/17 atrial strips from 15/15 patients chronically treated with β blockers. ICI 118551 (50 nmol/l) blocked the (−)-adrenaline-evoked contractions in 3/4 atrial strips from 3/4 patients not treated with β blockers and 17/20 atrial strips from 15/18 patients chronically treated with β blockers. The incidence of arrhythmic contractions evoked by both (−)-noradrenaline and (−)-adrenaline was higher in chronically β blocked patients than in non β blocked patients. We conclude that both β1- and β2-adrenoceptors mediate atrial arrhythmias and that the generation of these arrhythmias is facilitated by chronic β1-adrenoceptor blockade.

Key words

β1-adrenoceptors β2-adrenoceptors Human atrium Noradrenaline Adrenaline Arrhythmias 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berlin JR, Cannell MB, Lederer WS (1989) Cellular origin of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium. Circ Res 65:115–126Google Scholar
  2. Coumel P, Escoubet B, Attuel P (1984) Beta-blocking therapy in atrial and ventricular tachyarrhythmias. Experience with nadolol. Am Heart J 108:1098–1108Google Scholar
  3. Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (−)-propranolol for β1- and β2-adrenoreceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (−)-noradrenaline and (−)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331:60–70Google Scholar
  4. Hall JA, Kaumann AJ, Brown MJ (1990) Selective β1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through β2-adrenoceptors in human atrial myocardium. Circ Res 66:1610–1623Google Scholar
  5. Hall JA, Petch MC, Brown MJ (1991) In vivo demonstration of cardiac β2-adrenoceptor sensitisation by β1-antagonist treatment. Circ Res 69:959–964Google Scholar
  6. Kaumann AJ, Lemoine H (1987) β-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium: Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 335:403–411Google Scholar
  7. Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ (1989a) A comparison of the effects of adrenaline and noradrenaline on human heart: The role of β1- and β2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 [Suppl B]:29–37Google Scholar
  8. Kaumann AJ, Lemoine H, Schwederski-Menke U, Ehle B (1989b) Relations between β-adrenoceptor occupancy and increases of contractile force and adenylate cyclase activity induced by catecholamines in human ventricular myocardium. Acute desensitization and comparison with feline ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 339:99–112Google Scholar
  9. Lemoine H, Schoenell H, Kaumann AJ (1988) Contribution of β1- and β2-adrenoceptors of human atrium and ventricle to the effects of noradrenaline and adrenaline as assessed with (−)-atenolol. Br J Pharmacol 95:55–66Google Scholar
  10. Michel MC, Pingsmann A, Beckeringh JJ, Zerkowski HR, Doetsch N, Brodde O-E (1988) Selective regulation of β1- and β2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol 94:685–692Google Scholar
  11. Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC (1984) Arrhythmias after coronary bypass surgery. Br Heart J 51:618–621Google Scholar
  12. Prichard BNC, Tomlinson B, Walden RJ, Bhattacharjee P (1983) The β-adrenergic blockade withdrawal phenomenon. J Cardiovasc Pharmacol 5 [Suppl 1]:S56-S62Google Scholar
  13. Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw Hill, New York, pp 95–110Google Scholar
  14. Singer DH (1990) Automaticity in human cardiac tissue. In: Rosen MJ, Janse MJ, Wit AL (eds) Cardiac electrophysiology. Futura Publishing, Mount Kisco NY, pp 247–263Google Scholar
  15. Tsien TW, Bean BP, Hess P, Lansman JB, Nilius B, Nowycky MC (1986) Mechanisms of calcium channel modulation by β-adrenergic agents and dihydropyridine calcium agonists. J Mol Cell Cardiol 18: 691–710Google Scholar
  16. Wit AL, Rosen MR (1986) Afterdepolarizations and triggered activity. In: Fozzard H (ed) The heart and cardiovascular system. New York, Raven Press, pp 1449–1490Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Alberto J. Kaumann
    • 1
    • 2
  • Louise Sanders
    • 1
    • 2
  1. 1.Clinical Pharmacology UnitUniversity of CambridgeCambridgeUK
  2. 2.Human Pharmacology LaboratoryAFRC Babraham InstituteBabrahamUK

Personalised recommendations